Table 5.
Multivariate Cox hazards analyses of predictors of 4-year MACEs, adjusted for major confounders.
| Variables | Model 1 | Model 2 | ||
|---|---|---|---|---|
| HR (95%CI) | P | HR (95%CI) | P | |
| High apo-C3 | 2.6498 (1.0465–6.7096) | 0.0398* | 2.9415 (1.2163–7.1139) | 0.0166* |
| %NC | 1.1025 (1.0157–1.1967) | 0.0197* | 1.1021 (1.0127–1.1994) | 0.0243* |
| LDL-C | 1.0014 (0.9810–1.0163) | 0.8968 | ||
| Apo-B | 0.9883 (0.9611–1.0163) | 0.4094 | ||
| Apo-A1 | 1.0076 (0.9887–1.0268) | 0.4318 | ||
| eGFR | 1.0064 (0.9812–1.0322) | 0.6242 | ||
MACE Major cardiovascular event; HR Hazard ratio; CI Confidence interval; apo-C3 Apolipoprotein C3; high apo-C3 Patients with apo-C3 > 8.5 mg/dL; %NC percentage of the plaque volume that is a necrotic core; LDL-C low-density lipoprotein cholesterol; eGFR estimated glomerular filtration rate. * P < 0.05.